Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ1359-0,73
KB10460,00
PKN152,44152,51,53
Msft494,7494,841,51
Nokia8,3488,358-1,04
IBM232,02232,24-1,57
Mercedes-Benz Group AG46,7446,75-1,08
PFE26,0226,030,83
06.08.2026 16:17:57
Indexy online
AD Index online
select
AD Index online
 

  • 06.08.2026 16:12:34
West Pharm Svc (WST, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
349,68 -0,35 -1,23 6 280 142
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 06.08.2026
Popis společnosti
Obecné informace
Název společnostiWest Pharmaceutical Services Inc
TickerWST
Kmenové akcie:Ordinary Shares
RICWST
ISIN-
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky30.06.2026
Počet zaměstnanců k 31.12.2025 10 800
Akcie v oběhu k 20.07.2026 70 375 762
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice530 Herman O. West Drive
MěstoEXTON
PSČ19341
ZeměUnited States
Kontatní osobaJohn Sweeny
Funkce kontaktní osobyVice President - Investor Relations
Telefon16 105 942 900
Fax18003459800
Kontatní telefon14 847 900 373

Business Summary: West Pharmaceutical Services Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its segments include Proprietary Products and West Vantage. Its Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery systems, along with analytical lab services and other integrated services and solutions, primarily for biologic, generic and pharmaceutical drug customers. Its West Vantage segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, as well as combination product assembly and packaging, primarily for pharmaceutical, diagnostic, and medical device customers. It also maintains collaborations to share technologies and market products with affiliates in Japan and Mexico. Its customers include generic, pharmaceutical, diagnostic, and medical device companies.
Financial Summary: BRIEF: For the six months ended 30 June 2026, West Pharmaceutical Services Inc revenues increased 17% to $1.72B. Net income increased 32% to $292.8M. Revenues reflect Proprietary Products segment increase of 20% to $1.42B, Contract-Manufactured Products segment increase of 7% to $300.3M, Europe Middle East and Africa segment increase of 21% to $798.4M, Americas segment increase of 11% to $764M.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSMedical Laboratories
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICSMedical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICSFabric Coating Mills
NAICSAll Other Miscellaneous Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Medical Laboratories
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Medical Laboratories
SICSurgical And Medical Instruments
SICMedical Laboratories
SICDrugs/proprietaries/sundries
SICMedical And Hospital Equipment
SICFinishing Plants, Manmade
SICManufacturing Industries, Nec
SICCommercial Physical Research



  • Poslední aktualizace: 06.08.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Non-Independent Chairman of the Board, President, Chief Executive OfficerEric Green5624.05.202224.04.2015
President, Chief Executive Officer, DirectorMichel Lagarde5231.08.202631.08.2026
Chief Financial Officer, Senior Vice PresidentRobert Mcmahon5604.08.202504.08.2025
Chief Human Resources Officer, Senior Vice PresidentAnnette Favorite6105.10.201505.10.2015
Senior Vice President, General Counsel, Corporate SecretaryNorman Finch61
Senior Vice President, Chief Proprietary Segment OfficerShane Campbell4505.05.202505.05.2025
Senior Vice President - Strategy and Corporate DevelopmentJudy Poussot48
Chief Accounting Officer, Vice President - FinanceChad Winters4705.05.2020